Clinical Trials Browser

Phase 2 × Pancreatic Neuroendocrine Tumour Metastatic × Everolimus × Clear all

NCT02305810 2018-11-07

A Biological Prospective Study in Patients With Metastatic Pancreatic NETs Treated With Everolimus

Phase 2 Completed

EndocrineGastrointestinal

Pancreatic Neuroendocrine Tumour Metastatic